YCM
VIR icon

Yousif Capital Management’s Vir Biotechnology VIR Stock Holding History

Yousif Capital Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$290K Buy
28,453
+1,305
+5% +$12.4K ﹤0.01% 1516
2026
Q1 		$243K Buy
27,148
+3,555
+15% +$28.3K ﹤0.01% 1690
2025
Q4 		$142K Sell
23,593
-250
-1% -$1.49K ﹤0.01% 1830
2025
Q3 		$136K Sell
23,843
-3,709
-13% -$19K ﹤0.01% 1849
2025
Q2 		$139K Hold
27,552
– – ﹤0.01% 1876
2025
Q1 		$179K Sell
27,552
-30
-0.1% -$267 ﹤0.01% 1833
2024
Q4 		$202K Sell
27,582
-385
-1% -$3.04K ﹤0.01% 1824
2024
Q3 		$209K Buy
27,967
+205
+0.7% +$1.78K ﹤0.01% 1847
2024
Q2 		$247K Sell
27,762
-3,986
-13% -$38.2K ﹤0.01% 1767
2024
Q1 		$322K Sell
31,748
-3,605
-10% -$36.7K ﹤0.01% 1707
2023
Q4 		$356K Sell
35,353
-5,565
-14% -$50.9K ﹤0.01% 1694
2023
Q3 		$383K Buy
40,918
+998
+3% +$14.2K ﹤0.01% 1610
2023
Q2 		$979K Sell
39,920
-2,620
-6% -$65.8K 0.01% 1173
2023
Q1 		$990K Sell
42,540
-9,105
-18% -$233K 0.01% 1154
2022
Q4 		$1.31M Sell
51,645
-14,780
-22% -$362K 0.02% 1025
2022
Q3 		$1.28M Sell
66,425
-108
-0.2% -$2.75K 0.02% 1035
2022
Q2 		$1.7M Buy
+66,533
New +$1.55M 0.02% 924

Other funds holding VIR

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FG
Foster Group West Des Moines, Iowa $3.76B AUM 21.29% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Yousif Capital Management's VIR Position: Q2 2026 in Review

Yousif Capital Management increased its Vir Biotechnology (VIR) stake by 4.8% in Q2 2026, buying an estimated $12.4K and bringing the position to 28,453 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #1516.

Yousif Capital Management first reported a position in VIR in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.7M in Q2 2022. 14 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Yousif Capital Management held 28,453 shares of Vir Biotechnology worth $290K as of Q2 2026.
  • Yousif Capital Management bought 1,305 Vir Biotechnology shares in Q2 2026, an estimated $12.4K.
  • Vir Biotechnology made up ﹤0.01% of Yousif Capital Management's portfolio in Q2 2026, its #1516 holding.
  • Yousif Capital Management first reported a position in Vir Biotechnology in Q2 2022 and has held it in 17 quarters since.
  • Yousif Capital Management's Vir Biotechnology position peaked at $1.7M in Q2 2022.
  • 14 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.